Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical management of hereditary breast cancer syndromes.

Journal of mammary gland biology and neoplasia - 1 Apr 2011

Clark Amy S, Domchek Susan M

Abstract excerpt

Over the past 15 years there has been substantial improvement in the understanding of hereditary breast cancer. Germline genetic testing for mutations in BRCA1, BRCA2, PTEN and TP53 allows for the identification of individuals at increased risk for breast, ovarian and other cancers. Advances in screening, prevention and treatment have led to improved clinical management which is best defined for BRCA1 and BRCA2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Early Detection of Cancer
Share to Early Diagnosis

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Magnetic Resonance Imaging

Share to Mammography

Share to Neoplastic Syndromes, Hereditary

Source

Identifiers

PMID: 21360002
DOI: 10.1007/s10911-011-9200-x

Genes

BRCA1
BRCA2
PTEN

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical management of hereditary breast cancer syndromes.PMID 21360002Read ↗

Genetic predisposition syndromes and their management.Semantic proximity Read ↗

Surgical Management of Hereditary Breast Cancer.Semantic proximity Read ↗

Risk for breast cancer and management of unaffected individuals with non-BRCA hereditary breast cancer.Semantic proximity Read ↗

Hereditary breast cancer syndromes and clinical implications.Semantic proximity Read ↗

Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline.Semantic proximity Read ↗

Management of women at increased risk for hereditary breast cancer.Semantic proximity Read ↗

Management of breast cancer risk in BRCA1/2 mutation carriers who are unaffected with cancer.Semantic proximity Read ↗

Hereditary breast cancer: part II. Management of hereditary breast cancer: implications of molecular genetics and pathology.Semantic proximity Read ↗

Breast cancer predisposition syndromes.Semantic proximity Read ↗

Systemic Treatment Strategies for Patients with Hereditary Breast Cancer Syndromes.Semantic proximity Read ↗

Management of hereditary breast cancer. European Familial Breast Cancer Collaborative Group.Semantic proximity Read ↗

Management updates for women with a BRCA1 or BRCA2 mutation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.